You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline

You are reading 1 of 2 free-access articles allowed for 30 days

Neurologists need to be aware of rare CAAri, according to Northern Irish study

By Mindo - 18th Jun 2021 | 15 views

Irish Neurology Association 57th Annual Meeting, Virtual, 27-28 May 2021

The second session on the second day of the meeting was on the topic of cognitive and parkinson’s disease. During this session Dr Rachel Todd, Neurology Specialist Registrar, Royal Victoria Hospital, Belfast, presented
her study of cerebral amyloid angiopathy (CAAri)-related inflammation in Northern Ireland.

Dr Todd’s study was an epidemiological, clinical and radiological one spanning 10 years from 2011 to 2021, which aimed to reveal the incidence and prevalence of CAAri across Northern Ireland, to identify the range of clinical and radiological features and, further, to identify treatments given (if any) along with clinical outcomes. It is one of the first of its kind in western countries.

Cerebral amyloid angiopathy-related inflammation (CAAri) is a subtype of cerebral amyloid angiopathy (CAA), which is less reported. Although it has been recognised for 25 years, there remains a paucity of epidemiological data on the conditions. Observational reports on randomised control trials of effective therapy are only beginning to emerge, however, as yet there is no evidence of effective therapy in affected patients.

CAAri usually presents with subacute cognitive decline, seizures, focal deficit and headaches in patients over the age of 40 years. CAAri relies on pathology for a definite diagnosis. However, MRI would reveal asymmetric unifocal or multifocal WMH lesions, which extend to the immediately subcortical white matter. Corticosubcortical haemorrhagic lesions, cerebral microbleed, cerebral microbleed or cortical superficial siderosis may also be seen.

In the study a variety of treatments were used, including steroids in isolation, steroids with rituximab, steroids with mycophenolate mofetil, and steroids with cyclophosphamide. Over the course of the study, some patients experienced relapses, although Dr Todd noted that the numbers involved were too small to draw inferences. Although this is a rare condition, with an incidence of approximately one per million population per year, Dr Todd asserted that it is certainly a
condition which neurologists “need to be aware of”.

Leave a Reply

Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read